Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
The tirzepatide injection may include specific needles or pen devices designed for optimal delivery of the medication
Ans: The GLP-1 Receptor Agonist Market was valued at USD 60.6 billion in 2025
Moreover, Semaglutide GLP-1 and Liraglutide have been shown to have beneficial effects on cardiovascular risk factors
Exercise but not metformin improves health-related quality of life and mood states in older adults with type 2 diabetes
Read the guide Prior authorization New CMS rules, timeline protections, and what Washington beneficiaries can do when a plan delays or denies a drug or procedure authorization
